Frederick G. Vogt - 05 Jun 2026 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Reporting relationship: Interim CEO & General Counsel, Director
Issuer ticker: IOVA
Reported as of: 05 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2026, 17:03:00 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Frederick G. Vogt

Key filing fact

Frederick G. Vogt filed Form 4 for IOVANCE BIOTHERAPEUTICS, INC. (IOVA) on 09 Jun 2026.

Key facts

This page summarizes Frederick G. Vogt's Form 4 filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2026, 17:03.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001719678 Primary reporting owner

Vogt Frederick G

Relationship: Interim CEO & General Counsel, Director
Address: C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS
Signature: /s/ Frederick G. Vogt
Signature date: 09 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IOVA transaction

Common Stock

Options Exercise

Transaction value
Shares: +15,625
Change %: +2.8%
Price: $0.000000^*
Shares after: 569,130
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F1

IOVA transaction

Common Stock

Tax liability

Transaction value
Shares: -6,638
Change %: -1.2%
Price: $4.23^*
Shares after: 562,492
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IOVA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -15,625
Change %: -12%
Price: $0.000000^*
Shares after: 109,382
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Common stock
Underlying amount: 15,625
Exercise price
Footnotes: F4, F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Footnote F2

Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

Footnote F3

Represents common stock remaining after deducting the common stock withheld for taxes.

Footnote F4

Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Footnote F5

The remaining RSUs will vest in equal quarterly installments.

Footnote F6

Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.